| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CTVA | Common Stock | Options Exercise | $1,700,891 | +37,672 | +30% | $45.15 | 164,633 | 26 Nov 2024 | Direct | F1 |
| transaction | CTVA | Common Stock | Sale | $2,388,367 | -37,672 | -23% | $63.40 | 126,961 | 26 Nov 2024 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CTVA | Non-Qualified Stock Option | Options Exercise | $0 | -37,672 | -100% | $0.000000 | 0 | 26 Nov 2024 | Common Stock | 37,672 | $45.15 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Includes acquisition of 61.9115 shares pursuant to dividend reinvestment. |
| F2 | The price reported represents the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.065 to $63.675, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | This option is fully vested and exercisable. |